NCCN-protocol care · 96.9% 1-yr breast cancer survival · ArogyaSri, CGHS & cashless insurance accepted · Free second opinion
1800 202 8726
Pediatric Cancer · Genetics & Risk

Down syndrome & childhood leukemia — what parents need to know

Medically reviewed by Dr. Naresh Gundu, Medical Oncologist · Last reviewed June 2026

Children with Down syndrome (trisomy 21) have a higher-than-average chance of developing certain types of leukemia compared to the general population. Understanding this risk helps you ask the right questions, recognise early signs, and get specialist input at the right time — without living in constant fear.

  • Most children with Down syndrome do not develop leukemia — but the elevated risk is real and worth monitoring with your paediatrician.
  • Early detection is the single most powerful factor — blood count changes found early almost always mean simpler, more effective treatment.
  • Down syndrome-associated leukemia responds well to treatment — specialist paediatric oncology care is available at CION Hyderabad.
  • You deserve a 45-minute consultation — not a hurried five-minute answer. Our team walks this journey with you.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Talk to a Paediatric Oncologist

₹950   Today: FREE  ·  Including free written second opinion

Specialists in Down syndrome-related blood cancers
Tumor board review — no single-doctor decisions
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)
Understanding the connection

Down syndrome leukemia — why trisomy 21 affects blood cell development

Down syndrome is caused by an extra copy of chromosome 21 — a condition called trisomy 21. That extra chromosome changes how the body’s bone marrow produces blood cells, particularly in foetal development and early infancy. As a result, children with Down syndrome have a meaningfully higher risk of developing leukemia than children in the general population. This does not mean leukemia is inevitable or even likely — but it does mean that staying alert to blood count changes is worthwhile.

The two main types of leukemia associated with trisomy 21 are Acute Lymphoblastic Leukaemia (ALL) and Acute Myeloid Leukaemia (AML). In children with Down syndrome, AML tends to be of a specific subtype called Acute Megakaryoblastic Leukaemia (AMKL), which affects the cells that normally go on to form platelets. ALL in children with Down syndrome behaves somewhat differently from ALL in other children — often responding very well to treatment, though with a need for more careful side-effect monitoring.

Before either of those conditions develops, some newborns with Down syndrome experience a pre-leukemic state called Transient Abnormal Myelopoiesis (TAM), sometimes called Transient Myeloproliferative Disorder (TMD). In TAM, abnormal blast cells appear in the blood at birth or in the first few weeks of life. The important thing to know about TAM is that it resolves on its own in the large majority of affected infants. However, a proportion of children who had TAM as newborns later develop AML, usually within the first four years of life. If your newborn was found to have TAM, close follow-up with a paediatric haematologist is essential.

The risk associated with Down syndrome and leukemia has been extensively studied, and this knowledge has directly shaped treatment protocols. Children in this group often respond to lower doses of certain medicines compared to children without Down syndrome — which means treatment can sometimes be gentler while still being highly effective. A paediatric oncologist who is experienced with Down syndrome-associated blood cancers will factor all of this into the treatment plan from day one.

What this means for you as a parent: you do not need to read every blood count yourself, and you should not carry fear of leukemia as a constant background dread. What you can do is keep your child’s paediatric appointments, mention any new symptoms promptly, and know that if a blood count abnormality is ever found, there are specialists ready to guide you with honesty and care. You will never be left with a rushed five-minute conversation. We walk this journey with you.

Did you know?

Children with Down syndrome who develop AML (specifically the AMKL subtype) often have better outcomes with AML treatment than children without Down syndrome, partly because their leukaemia cells are more sensitive to certain standard medicines. This is one of the few situations in oncology where the underlying genetic condition may actually work in a child’s favour during treatment. Early identification and specialist-led care remain the most important factors. Source: established paediatric haematology literature; please confirm specific figures with your oncologist before quoting.

What to watch for

Signs in your child that should prompt a blood count — trisomy 21 leukemia risk

Most children with Down syndrome will never show any of these signs in the context of leukemia. Every item on this list also has many harmless and common explanations. But if any of the following appear in your child — especially if more than one is present at the same time, or if a single sign persists for more than two to three weeks without a clear cause — please book a visit with your paediatrician and ask for a full blood count (FBC or CBC).

Unusual paleness: Pallor that is new or noticeably worse than usual, particularly around the lips, inside the lower eyelids, or the fingernail beds. This can be a sign that the red blood cell count is low (anaemia), which is common in leukemia because the marrow fills with leukemia cells and cannot produce enough healthy red cells.

Persistent tiredness or low energy: Every child with Down syndrome has their own baseline energy level. If your child seems significantly more tired than usual — sleeping more, less interested in play, or harder to rouse — and it is lasting more than a week or two without a cold or illness to explain it, that is worth a doctor’s review.

Easy bruising or unexplained bruises: Small children bruise on their shins from normal play, but bruises on the trunk, back, or face without a clear injury, or an unusual number of bruises, can reflect low platelet counts (thrombocytopenia).

Petechiae: These are tiny flat red or purple spots on the skin that do not blanch (go white) when you press them. They are caused by small bleeds under the skin from low platelets. Petechiae often appear on the legs, feet, or around the mouth.

Swollen lymph glands that do not go away: Lymph glands in the neck, armpit, or groin that are swollen and have been there for more than three to four weeks — without a recent infection to explain them — deserve evaluation.

Repeated infections that take longer to clear: Because leukemia crowds out the normal white blood cells that fight infection, affected children often have more frequent infections or take much longer than expected to recover from them.

Prolonged fever: A fever that lasts more than five to seven days with no identified infection as its cause should prompt a blood count.

If you are in doubt, do not wait and worry. A full blood count is a simple, fast test. A normal result is genuinely reassuring. An abnormal result — found early — leads to more effective treatment. Either way, you are better informed.

Talk to Our Team Today

Free consultation for all paediatric cancer enquiries — no referral needed.

or
Call 1800 202 8726
12+ Centres in Hyderabad · Pick yours

CION cancer care is closer than you think.

We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.

Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.

Help me pick the right centre
Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Concerned about your child’s blood counts?

You deserve a clear answer, not a hurried appointment. Our paediatric oncology team gives every family a full 45-minute consultation — tumor board led, transparent, and driven by what is right for your child.

The clinical pathway

How leukemia is caught early in a child with Down syndrome

If a paediatrician is concerned about a blood count result, this is the sequence of steps that typically follows. Understanding the process in advance means there are fewer surprises — and you can ask better questions at each stage.

Full blood count and blood film

The first test is always a full blood count (FBC or CBC) with a blood film. This is a simple blood draw that measures the levels of red blood cells, white blood cells, and platelets, and looks at the shape and size of those cells under a microscope. An abnormal result — for example, very high or very low white cell counts, anaemia, or low platelets, or the appearance of abnormal cells called blasts in the film — will prompt further investigation. A normal result at this stage is genuinely reassuring and will usually mean monitoring continues at regular intervals rather than any immediate action.

Referral to a paediatric haematologist or oncologist

If the blood count is abnormal in a way that raises concern, your paediatrician will refer your child to a specialist. In Hyderabad, this means a paediatric haematologist or paediatric oncologist experienced in childhood blood cancers. At CION, you will not wait months for this consultation. The team will review your child’s full history, including their Down syndrome diagnosis and any prior TAM, as part of the first assessment. You will be seen as a team — medical, haematology, and if needed paediatric surgical or radiation oncology — and every case goes to our tumor board before any treatment recommendation is made.

Bone marrow aspirate and biopsy

A blood count alone cannot confirm or rule out leukemia. The definitive test is a bone marrow aspirate and biopsy — a procedure that takes a small sample of marrow from the back of the hip bone. In children, this is done under general anaesthesia or deep sedation so your child does not feel the procedure. The marrow is then examined under a microscope (morphology), tested with immunophenotyping to identify the exact type of abnormal cell, and tested for genetic or chromosomal changes that help classify the leukemia and guide the treatment plan. The entire process from sample to results typically takes a few days, depending on the complexity of the tests requested.

Lumbar puncture (spinal fluid check)

A lumbar puncture is usually done at the same time as the bone marrow test — again under sedation — to check whether any leukemia cells have reached the cerebrospinal fluid (the fluid around the brain and spinal cord). This step is standard in leukemia diagnosis because some types of leukemia can spread to the central nervous system, which affects treatment planning. If the spinal fluid is clear of leukemia cells, treatment can be more targeted. If cells are found, the treatment protocol is adjusted accordingly. The procedure itself is brief and your child is asleep throughout.

Tumour board review and treatment planning

Before any treatment begins, every CION paediatric case is reviewed by our multidisciplinary tumour board — a structured meeting of medical oncologists, haematologists, radiation oncologists, paediatric surgeons, and allied care specialists. For a child with Down syndrome and leukemia, this is especially important because the treatment protocol needs to be carefully calibrated: children with trisomy 21 may be more sensitive to certain medicines, and the specific subtype of leukemia (ALL vs. AML-AMKL, or Down syndrome-specific protocols) determines the entire treatment plan. You will receive a clear explanation of the recommended plan, the reasons behind every decision, and the realistic expected timeline before any treatment starts.

Treatment, monitoring, and allied care through every phase

Treatment for leukemia in children with Down syndrome follows the same broad phases as in other children — induction (to achieve remission), consolidation (to eliminate remaining cells), and for ALL, a maintenance phase that continues for one to two years. What differs is the dose adjustment and the more attentive side-effect monitoring that children with Down syndrome need throughout. Allied care — nutritional support, psychological support for your child and your family, and regular developmental review — is part of every CION treatment plan from the very first day, not an afterthought. We do not separate medical treatment from the rest of your child’s wellbeing.

Related pages

Learn more about childhood leukemia overall, or read about ALL (acute lymphoblastic leukemia) in children. If your child has already been diagnosed, our minimal residual disease monitoring page explains how CION tracks treatment response. Back to the paediatric cancer hub.

Get a Second Opinion — Free

Already seen another specialist? Our paediatric oncology team will review your child’s reports, bone marrow results, and proposed treatment plan at no charge.

or
Call 1800 202 8726
Tumor board · 17 oncologists · 35+ centres

You deserve more than a rushed five minutes

Every family at CION receives a 45-minute consultation — with a team, not just one doctor. Our tumour board reviews every paediatric case before any decision is made. Transparent costs. No unnecessary tests. Decisions for healing, not billing.

Real Stories. Real Voices.

15,000+ patients chose CION. Hear from them directly.

These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.

4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Successful Chemotherapy Done by Dr. C Raghavendra Reddy

Successful Chemotherapy Done by Dr. C Raghavendra Reddy

Watch video →
Surgery, Chemo & Radiation Done by  Dr. Imaduddin, Dr. Vinay, Dr. Owais, Dr. Kirti

Surgery, Chemo & Radiation Done by Dr. Imaduddin, Dr. Vinay, Dr. Owais, Dr. Kirti

Watch video →
 Successful Radical Thymectomy Done by  Dr. Mohammed Imaduddin & Dr. Vinay Mamidala

Successful Radical Thymectomy Done by Dr. Mohammed Imaduddin & Dr. Vinay Mamidala

Watch video →
Successful Surgery Done  by Dr. Rajender Byshetty

Successful Surgery Done by Dr. Rajender Byshetty

Watch video →
Successful Chemo & Surgery Done by  Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →
Successful Chemo & Surgery Done by  Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →
Successful Chemo & Radiation Done by Dr. Owais Mohammed & Dr. Kirti Ranjan Mohanty

Successful Chemo & Radiation Done by Dr. Owais Mohammed & Dr. Kirti Ranjan Mohanty

Watch video →
Successful Breast Cancer Surgery Done by Dr. Imaduddin Mohammed & Dr. Vinay Mamidala

Successful Breast Cancer Surgery Done by Dr. Imaduddin Mohammed & Dr. Vinay Mamidala

Watch video →
Successful Chemotherapy Done by Dr. Bharati Devi Gorantla

Successful Chemotherapy Done by Dr. Bharati Devi Gorantla

Watch video →
Successful Chemo & Surgery Done by Dr. Owais Mohammed & Dr. Imaduddin Mohammed

Successful Chemo & Surgery Done by Dr. Owais Mohammed & Dr. Imaduddin Mohammed

Watch video →
Successful Chemotherapy Done by Dr. Gundu Naresh

Successful Chemotherapy Done by Dr. Gundu Naresh

Watch video →
Successful Bone Marrow Transplantation - Neuroblastoma

Successful Bone Marrow Transplantation - Neuroblastoma

Watch video →
Successful Surgery & Chemo - Carcinoma of Caecum

Successful Surgery & Chemo - Carcinoma of Caecum

Watch video →
Successful Oral chemotherapy & mastectomy surgery

Successful Oral chemotherapy & mastectomy surgery

Watch video →
Successful Oral chemotherapy & mastectomy surgery

Successful Oral chemotherapy & mastectomy surgery

Watch video →
Successful Chemotherapy

Successful Chemotherapy

Watch video →
Successful Surgery by Dr. Mohammed Imaduddin

Successful Surgery by Dr. Mohammed Imaduddin

Watch video →
Successful Bone Marrow Transplantation

Successful Bone Marrow Transplantation

Watch video →
Successful Oral chemotherapy & mastectomy surgery

Successful Oral chemotherapy & mastectomy surgery

Watch video →
Successful Oral chemotherapy & mastectomy surgery

Successful Oral chemotherapy & mastectomy surgery

Watch video →
Successful Chemotherapy

Successful Chemotherapy

Watch video →
Successful Buccal Mucosa Surgery

Successful Buccal Mucosa Surgery

Watch video →
Successful Complex Surgery Mandibulectomy Reconstruction

Successful Complex Surgery Mandibulectomy Reconstruction

Watch video →
Common questions

Your questions about Down syndrome and leukemia — answered

Does every child with Down syndrome get leukemia?
No — most children with Down syndrome do not develop leukemia. The elevated risk is real and well-documented, but the great majority of children with trisomy 21 live without ever receiving a leukemia diagnosis. Because the risk is higher than in the general population, paediatricians do monitor children with Down syndrome more attentively for blood-count changes. If you have concerns, a conversation with your child’s paediatrician and, where appropriate, a paediatric haematologist or oncologist is the right first step — not because leukemia is inevitable, but because early detection makes treatment significantly more effective.
What type of leukemia is most common in children with Down syndrome?
Children with Down syndrome are at elevated risk of two main types of leukemia: Acute Lymphoblastic Leukaemia (ALL) and Acute Myeloid Leukaemia (AML) — specifically the AML subtype known as Acute Megakaryoblastic Leukaemia (AMKL). Infants with Down syndrome can also develop a pre-leukemic condition called Transient Abnormal Myelopoiesis (TAM), sometimes called Transient Myeloproliferative Disorder (TMD), which resolves on its own in most cases but requires monitoring because a proportion of affected infants later develop AML. The CION paediatric oncology team is experienced in recognising and managing each of these patterns.
What is Transient Abnormal Myelopoiesis (TAM) in newborns with Down syndrome?
Transient Abnormal Myelopoiesis (TAM), also called Transient Myeloproliferative Disorder (TMD), is a condition seen almost exclusively in newborns with Down syndrome. In TAM, the baby’s blood briefly contains abnormal blast cells that look similar to leukemia cells. In the majority of cases, TAM resolves on its own within the first few months of life without any treatment. However, some infants with TAM have complications requiring monitoring or support, and a proportion — roughly one in five — later develop AML, typically within the first four years of life. Because of this link, all newborns with Down syndrome who are found to have TAM should be followed closely by a paediatric haematologist. Please consult your child’s doctor for personalised guidance.
What blood count changes should I watch for in my child with Down syndrome?
You are not expected to interpret blood counts yourself — that is your paediatrician’s role. However, some signs at home that warrant a prompt doctor visit include: unusual paleness that is new or worsening; unexplained tiredness or low energy that is much greater than usual; easy bruising or bruises appearing without a clear injury; tiny flat red or purple spots on the skin (petechiae); swollen glands in the neck, armpit, or groin; repeated infections that take a long time to clear; or prolonged fever without an obvious cause. None of these signs proves leukemia — they each have many harmless explanations — but in a child with Down syndrome they should prompt a full blood count sooner rather than later.
Is leukemia in a child with Down syndrome treated the same way as in other children?
Not exactly. Children with Down syndrome and ALL often respond very well to standard treatment protocols, and some evidence suggests they may have better outcomes with ALL than their peers without Down syndrome. However, they are also more sensitive to certain chemotherapy-related side effects, so treatment doses and monitoring are adjusted accordingly. For the AML subtype (AMKL) that is most common in Down syndrome, specific treatment protocols designed for this group have shown good outcomes. The key is specialist care: a paediatric oncologist experienced with Down syndrome-associated leukemia tailors the treatment plan to the individual child. The CION tumor board reviews every case before any protocol begins.
Should my child with Down syndrome have regular blood tests to screen for leukemia?
Routine blood count monitoring for all children with Down syndrome is not universally mandated in every guideline, but many paediatric haematology teams do recommend periodic full blood counts — particularly in the first few years of life when TAM-related AML risk is highest. Whether your child needs this monitoring, and how frequently, depends on their age, whether they had TAM as a newborn, and their overall health. Speak with your child’s developmental paediatrician or request a referral to a paediatric haematologist for personalised guidance. Early detection of any blood count abnormality almost always means simpler, more effective treatment.
Pediatric Cancer A–Z

Explore All Pediatric Cancer Topics

Browse our complete library of parent-facing guides, grouped by topic — from warning signs and cancer types to diagnosis, treatment, side-effect care, survivorship and family support.

Call now Book free consultation